This Phase 2 trial tests whether adding rademikibart (a shot) to standard care can help adults and teens with asthma and type 2 inflammation avoid hospital visits or needing more steroids during an attack. About 160 participants will receive either the drug or a placebo. The main…
Phase: PHASE2 • Sponsor: Connect Biopharm LLC • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC